butyric acid has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, FS; Edwards-Prasad, J; Freed, CR; Kentroti, S; Kumar, S; La Rosa, FG; Prasad, KN; Vernadakis, A | 1 |
| Sharma, S; Singh, S; Taliyan, R | 1 |
2 other study(ies) available for butyric acid and oxidopamine
| Article | Year |
|---|---|
Characterization and transplantation of two neuronal cell lines with dopaminergic properties.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Bucladesine; Butyrates; Butyric Acid; Carrier Proteins; Cell Differentiation; Cell Line, Transformed; Cell Transplantation; Clone Cells; Cyclic AMP; Dopamine; Dopamine Plasma Membrane Transport Proteins; Intermediate Filament Proteins; Isoenzymes; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Mice; Nerve Tissue Proteins; Nestin; Neuroblastoma; Neurons; Oxidopamine; Phosphopyruvate Hydratase; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 1996 |
Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity.
Topics: Animals; Antiparkinson Agents; Apomorphine; Brain-Derived Neurotrophic Factor; Butyric Acid; Corpus Striatum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Hippocampus; Histamine Antagonists; Histone Deacetylases; Male; Motor Activity; Neuroimmunomodulation; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Rats, Wistar; Tumor Necrosis Factor-alpha | 2015 |